Seaport Therapeutics Funding: $330M Raised, Series A (2024)
Seaport Therapeutics is a Biotech company based in Boston, Massachusetts. It has raised $330M in total funding. Latest round: Series A.
Seaport Therapeutics funding overview
Seaport Therapeutics is a Biotech company based in Boston, Massachusetts. Seaport Therapeutics has raised $330M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in April 2024. The round record for Seaport Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include ARCH Venture Partners, Sofinnova Investments, Third Rock Ventures, PureTech Health. 4 distinct backers are named across the disclosed rounds.
Seaport Therapeutics at a glance
Total raised
$330M
Latest round
Series A
Latest round date
April 2024
Industry
Biotech
Headquarters
Boston, Massachusetts
Notable investors
ARCH Venture Partners, Sofinnova Investments, Third Rock Ventures, PureTech Health
Frequently asked about Seaport Therapeutics funding
How much has Seaport Therapeutics raised?
Seaport Therapeutics has raised $330M in total disclosed funding across the rounds on record.
Who has invested in Seaport Therapeutics?
ARCH Venture Partners, Sofinnova Investments, Third Rock Ventures, PureTech Health are named among the investors backing Seaport Therapeutics.
What was the latest Seaport Therapeutics funding round?
The most recent disclosed round is a Series A, announced in April 2024.
Where is Seaport Therapeutics based?
Seaport Therapeutics is based in Boston, Massachusetts.
What sector does Seaport Therapeutics operate in?
Seaport Therapeutics is tracked under Biotech from Boston, Massachusetts, with $330M in disclosed funding.
When did Seaport Therapeutics last raise?
The last disclosed Seaport Therapeutics round closed in April 2024 at Series A.
Totals shown for Seaport Therapeutics aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Boston and the investors behind them below.
